However, given the striatal changes that occur in Parkinson’s disease, replicating this work to characterise striatal gradients would be of interest—particularly given evidence of a link between striatal gradients and dopamine transporter availability in Parkinson’s disease (Oldehinkel et al., 2022). Here, SLC6A3 is linked to Parkinson disease.